Novartis Archives - Express Pharma

Novartis warns US plan to curb drug prices could hit key research

Dr Reddy’s reduces price of cardiovascular drug Cidmus

EMA seeks to issue guidance on liver damage from Novartis’s gene therapy

Novartis to uphold generic drug supply despite surging energy costs

US Supreme Court rebuffs Novartis, allows generic versions of MS drug

Novartis drug shown to ease symptoms of painful skin condition

Novartis to spin off generics business Sandoz next year

Novartis fails again to reuse anti-inflammatory drug to treat lung cancer

Novartis’s tislelizumab phase-III trial data shows survival results in esophageal cancer

EMA recommends marketing authorisation for Scemblix by Novartis